This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Chronic Pain Management: Optimizing Efficacy and Safety in Opioid Use—Your Questions Answered

Chronic Pain Management: Optimizing Efficacy and Safety in Opioid Use—Your Questions Answered

Format

Roundtable

Time to Complete

30 minutes

Released

March 28, 2016

Expires

June 28, 2017
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 Credit(s)TM

Accredited Provider



This educational activity is provided by Haymarket Medical Education.

Commercial Supporter

Supported by an educational grant from Teva Pharmaceuticals

Program Description

Opioid analgesics are a highly effective means of managing chronic pain, but they are not without adverse effects and risk for abuse, misuse, and diversion. In this activity, faculty experts review strategies to improve the safety of chronic opioid therapy, including the use of abuse-deterrent opioid formulations and careful patient assessment and counseling. They also provide practical guidance in response to learners’ questions.

Intended Audience

Pain specialists and other clinicians who provide care for patients with chronic pain

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Evaluate patients with chronic pain to identify those who may benefit from opioid therapy
  • Stratify patients with chronic pain according to low, moderate, or high risk for opioid misuse, abuse, or diversion
  • Individualize chronic pain treatment plans with attention to medication choice and dosing strategies intended to optimize outcomes and minimize risk
  • Communicate effectively with patients who experience chronic pain to facilitate a shared decision-making model of care

Conflict Of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

Faculty

Faculty Chair
Jeffrey A. Gudin, MD

Director, Pain Management and Palliative Care
Englewood Hospital and Medical Center
Englewood, NJ
Clinical Instructor in Anesthesiology
Icahn School of Medicine at Mount Sinai
New York, NY

Dr. Gudin is a consultant for AstraZeneca, Depomed, Inc., Iroko Pharmaceuticals, Kaleo Pharma, Kempharm, Inc., Purdue Pharma, Quest Diagnostics, Scilex Pharmaceuticals, and Teva Pharmaceuticals. Dr. Gudin serves on the speakers’ bureaus of AstraZeneca, Depomed, Inc., Iroko Pharmaceuticals, Kaleo Pharma, Purdue Pharma, and Teva Pharmaceuticals.

Charles E. Argoff, MD
Professor of Neurology
Albany Medical College
Director, Comprehensive Pain Center
Albany Medical Center
Albany, NY

Dr. Argoff receives grant/research support from Endo Pharmaceuticals, Forest Laboratories, Inc., and Lilly USA. He is a consultant for Ameritox, Collegium Pharmaceutical, Daiichi Sankyo, Inc., Depomed, Inc., Endo Pharmaceuticals, Lilly USA, ORx Pharmaceutical Corporation, and Teva Neurosciences. Dr. Argoff serves on the speakers’ bureaus of Allergan, Inc., Depomed, Inc., Endo Pharmaceuticals, Lilly USA, Millennium Pharmaceuticals, Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Steven P. Stanos, Jr, DO
Medical Director of Swedish Pain Services
Medical Director of Occupational Medicine Services
Swedish Health System
Seattle, WA

Dr. Stanos is a consultant for Daiichi Sankyo, Endo Pharmaceuticals, myMatrixx, Pfizer, Purdue Pharma, and Scilex Pharmaceuticals.

Accredited Provider Disclosure

Haymarket Medical Education staff involved in the planning and content review have no relevant financial relationships to disclose.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Haymarket Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only those credits commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Teva Pharmaceuticals and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Teva Pharmaceuticals and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact cmequestions@haymarketmedical.com.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue


Related to this activity